The UK has world-class strengths in life sciences, but healthcare innovation only delivers its full value when it reaches patients. The Medicines and Healthcare products Regulatory Agency (MHRA) is working to ensure regulation acts as a catalyst, not a barrier, to innovation – protecting patient safety while supporting access and growth.
As Cari-Anne Quinn highlights in this blog, Wales has particular strengths: a connected health and care system, a thriving life sciences sector and strong partnerships between government, healthcare, academia and industry.
As the UK-wide regulator, the MHRA is strengthening engagement with innovators across all four nations. More direct engagement in Wales, including the new programme of MHRA Liaison Days, is helping bring regulatory expertise closer to innovators and strengthen collaboration across the Welsh life sciences ecosystem.
Thank you to Cari-Anne for sharing her perspectives on how stronger collaboration can help turn innovation into better outcomes for patients and support growth across the UK.
Guest blog: Cari-Anne Quinn, Chief Executive Officer, Life Sciences Hub Wales
Health and care systems across the UK are under pressure, and Wales is no exception. Demand is rising, patients are waiting longer for diagnosis, treatment and support, pathways are becoming more complex, and teams are being asked to deliver more in a system that’s already stretched.
Innovation is often talked about as part of the answer, but it needs to be understood properly. It’s not about adding more technology into an already pressured system for the sake of it. It’s about identifying where systems are stuck, where delays are happening, and where proven solutions can help people move through care more safely and efficiently. Creating more capacity is important, but it is only part of the answer. We need to ask not only how we do more, but how we do things differently. Innovation only changes lives when it reaches patients.
Wales as a connected environment for adoption
This is where Life Sciences Hub Wales has a practical role to play. Our work is focussed on connecting the challenges recognised across health and social care with the people and organisations developing possible solutions. We bring partners together and help good ideas move beyond individual pilots and into wider use. For example, through our clinical engagement work, we’re working with clinical cancer teams and partners to connect frontline insight with evidence, so that innovation is focussed on the areas where it can make the greatest impact.
Excerpt from the official page. The original is authoritative. Continue reading at UK MHRA ↗